CEL-SCI Corporation is a clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system. The Company is focused on the development of product candidates and technologies, such as Multikine, an investigational immunotherapy under development for the potential treatment of certain head and neck cancers, and Ligand Epitope Antigen Presentation System (LEAPS), with several product candidates under development for the potential treatment of rheumatoid arthritis. Multikine is a biological medicinal immunotherapy comprising a mixture of natural cytokines and small biological molecules. Multikine is injected around the tumor and adjacent lymph nodes for three weeks as a first-line treatment before the standard of care (SOC), which is surgery followed by either radiotherapy or chemoradiotherapy. Multikines rationale for use is to incite a locoregional immune response against the tumor.
Read More
How much money does Cel Sci Corp make?
News & Events about Cel Sci Corp.
Globe Newswire
3years ago
NEW YORK, July 07, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of CEL-SCI Corporation (CEL-SCI or the Company) (NYSE:CVM). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation ...
Frequently Asked Questions
Frequently Asked Questions
What is Cel Sci Corp share price today?
Can Indians buy Cel Sci Corp shares?
How can I buy Cel Sci Corp shares from India?
Can Fractional shares of Cel Sci Corp be purchased?
What are the documents required to start investing in Cel Sci Corp stocks?
What is today’s traded volume of Cel Sci Corp?
What is today’s market capitalisation of Cel Sci Corp?
What is the 52-Week High and Low Range of Cel Sci Corp?
What percentage is Cel Sci Corp down from its 52-Week High?
What percentage is Cel Sci Corp up from its 52-Week Low?
Current Price
$0.5
$-0.06
(-10.71%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Kura Oncology Inc
$10.67
$-0.04 (-0.37 %)
Vericel Corporation
$56.37
$-0.15 (-0.27 %)
Mesoblast
$11.10
$0.10 (0.91 %)
Anavex Life Sciences Corp.
$8.14
$0.54 (7.11 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Kura Oncology Inc
$10.67
$-0.04 (-0.37 %)
Vericel Corporation
$56.37
$-0.15 (-0.27 %)
Mesoblast
$11.10
$0.10 (0.91 %)
Anavex Life Sciences Corp.
$8.14
$0.54 (7.11 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.